AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox

News HighlightsRecent headlines, though not directly related to Similarweb, highlight broader market forces at play: Trump’s Tariff Moves: New tariff announcements continue to roil industries and markets, especially in pharmaceuticals and minerals, potentially impacting tech and global supply chains. China’s Manufacturing Data: China's factory activity shrank in May, though signs of improvement hint at easing trade tensions and possible recovery. Crypto ETFs: REX Shares is planning
and ETFs, which could inject new capital into crypto-related tech companies, indirectly influencing Similarweb's market environment.Analyst Views & FundamentalsAnalyst sentiment is mixed, with Needham giving a recent Strong Buy rating, though the broader analyst consensus is fragmented. Here's the breakdown: Average Rating Score (Simple Mean): 5.00 Weighted Rating Score (Performance-Weighted): 6.04 Ratings Consistency: Divergent views among analysts; the market is optimistic but not aligned with the recent price decline. Price Trend vs. Ratings: The stock has fallen sharply (-8.56%) recently, which contrasts with the optimistic average ratings. This mismatch suggests caution.
Fundamental FactorsHere are the key fundamental factors with their latest values and corresponding internal diagnostic scores (0-10): Price-to-Book (PB): 3.10x — Internal score: 0.00 Price-to-Cash Flow (PCF): 68.80x — Internal score: 4.00 Gross Profit Margin (GPM): 79.67% — Internal score: 3.00 Net Income to Revenue: -15.18% — Internal score: 2.00 Profit-to-Market Value (Profit-MV): 43.72% — Internal score: 2.00 ROE (Return on Equity): -101.70% — Internal score: 1.00 Net Profit Margin (NPM): -6.03% — Internal score: 1.00 Asset-to-Market Value (Asset-MV): -43.78% — Internal score: 0.00 Cash-to-Market Value (Cash-MV): -104.89% — Internal score: 1.00
These numbers suggest a company under financial strain, with weak margins and poor equity returns. The internal diagnostic scores confirm the fundamentals are struggling.
Money-Flow TrendsFund flows show a mix of activity, but overall sentiment is negative: Small investors: 48.49% inflow ratio — trend is negative Medium investors: 50.76% inflow ratio — trend is positive Large investors: 48.05% inflow ratio — trend is negative Extra-large investors: 50.35% inflow ratio — trend is positiveWith a fund flow score of 7.85 (internal diagnostic score, 0-10), big money is still cautiously invested, but retail investors are pulling back. This divergence could signal uncertainty about the company's near-term prospects.
Key Technical SignalsTechnical analysis reveals a weak chart with more bearish signals than bullish ones: RSI Oversold: Score: 3.49 (internal diagnostic score) — signals potential buying opportunity but in a volatile environment. WR Oversold: Score: 2.14 (internal diagnostic score) — another sign of potential reversal but low confidence. MACD Death Cross: Score: 5.42 (internal diagnostic score) — bearish signal with moderate strength. Long Upper Shadow: Score: 4.03 (internal diagnostic score) — neutral but indicates indecision. Long Lower Shadow: Score: 6.33 (internal diagnostic score) — suggests some short-term support.Over the last 5 days, the stock has shown signs of RSI and WR Oversold conditions multiple times. However, the MACD Death Cross and Long Upper Shadow patterns have emerged as bearish signals. The technical score is 4.28 (internal diagnostic score, 0-10), indicating weak technology and caution is warranted.
ConclusionSimilarweb is in a precarious position. While some technical indicators point to potential short-term buying opportunities, the overall trend remains weak and uncertain. Fundamentals are poor, and the stock is down -8.56% recently. Analysts are optimistic but not unified in their views.
Actionable Takeaway: Consider waiting for a clearer trend or additional catalysts before taking action. Investors should closely monitor earnings or regulatory news for a potential turning point.
A quantitative finance AI researcher dedicated to uncovering winning stock strategies through rigorous backtesting and data-driven analysis.

Dec.04 2025

Dec.04 2025

Dec.04 2025

Dec.04 2025

Dec.04 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet